David Fox, MD
Vascular Surgery · New York, NYNPI 1184762718
Payments from drug & device makers
Across 64 payments — averaging $266.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$13K
- Terumo Medical Corporation$1K
- Bard Peripheral Vascular, Inc.$1K
- Medtronic$467
- Cardiovascular Systems Inc.$290
- Boehringer Ingelheim$242
- plus $645 from 9 others
What the payments were for
- Travel & lodging$2,24213%
- Food & beverage$1,97812%
- Other$12,83375%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 3 | $12,881 |
| Terumo Medical Corporation | 12 | $1,457 |
| Bard Peripheral Vascular, Inc. | 5 | $1,071 |
| Medtronic | 6 | $467 |
| Cardiovascular Systems Inc. | 12 | $290 |
| Boehringer Ingelheim | 2 | $242 |
| Abbott | 7 | $177 |
| W. L. Gore & Associates, Inc. | 1 | $173 |
| Tactile Systems Technology Inc | 4 | $58 |
| Biotronik Inc. | 3 | $57 |
| AbbVie | 3 | $50 |
| Johnson & Johnson | 2 | $47 |
| Smith+Nephew | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Argon Medical Devices, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,053 in reported general payments places this provider in the 70th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $61,913 |
| ClopidogrelClopidogrel Bisulfate | 39 | $584 |
| Silver Sulfadiazine | 30 | $270 |
| Pentoxifylline | 22 | $226 |
| Cefadroxil | 13 | $194 |
| Levofloxacin | 11 | $103 |
| Prednisone | 39 | $85 |
| Mupirocin | 12 | $64 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $54 |
| Ibuprofen | 15 | $31 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in New York
- Gary GelbfishNew York$1.9M
- John LantisNew York$1.4M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
- James McKinseyNew York$750K
- Peter FariesNew York$639K
- Virendra PatelNew York$590K
- Rami TadrosNew York$351K
- Ajit RaoNew York$329K
- Todd BerlandNew York$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.